- Highest bridge to human heart transplant rate of any approved heart device, 79%
- Nearly 1,300 implants account for more than 350 patient years on the Total Artificial Heart
Freedom® Portable Driver
European CE Mark: March 1, 2010
Health Canada: May 25, 2011
FDA: Undergoing an Investigational Device Exemption (IDE) clinical study in the U.S.
Download the Freedom Driver Fact Sheet
The Freedom® portable driver is the world's first wearable power supply for the SynCardia Total Artificial Heart.
When eligible patients become stable, they can be switched from the C2 hospital driver to the Freedom portable driver, which provides the patient with greater mobility. Patients who meet discharge criteria can then leave the hospital to wait for a matching donor heart at home and in their communities.
Light and Wearable
Weighing 13.5 pounds (approx. 6 kg), the Freedom portable driver is designed to be worn by the patient in the Backpack or Shoulder Bag.
The Freedom driver is powered by two lithium-ion batteries that are re-charged using a standard electrical outlet or the cigarette lighter adaptor in a car. This allows patients to recharge their batteries while traveling and at night while they are sleeping.
FDA Clinical Study
On April 24, 2012, SynCardia completed the minimum enrollment required by the IDE clinical study of the Freedom portable driver. >> See Clinical Trials
Service by Replacement
SynCardia designed, manufactures and services the Freedom portable driver. No on-site repair or inventory of parts is required by the hospital. Drivers are delivered and returned via express delivery service.
*CAUTION – The Freedom driver system is an investigational device, limited by United States law to investigational use.
The Freedom portable driver is the world's first wearable power supply for the SynCardia Total Artificial Heart.
The Freedom Backback
The Freedom Shoulder Bag
NEXT ›› Regulatory Approvals